✦ LIBER ✦

The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections

✍ Scribed by Donald G. Therasse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Risk-Benefit Assessment of Levofloxaci

✍ Dr Steven J. Martin, Rose Jung, Cory G. Garvin 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 223 KB

Incidence of Respiratory Tract Infection

✍ Baggish, J.S.; Bexon, M.; Rojavin, M.; Zenker, O.; Berger, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Ceftazidime in the treatment of respirat

✍ L.H. Loebis 📂 Article 📅 1982 🏛 Springer Netherlands 🌐 English ⚖ 88 KB

Clinical utility of the new fluoroquinol

✍ Blondeau, Joseph M 📂 Article 📅 2001 🏛 Informa plc 🌐 English ⚖ 160 KB

A randomized, open-label, prospective, m

✍ Chaudhary, Manu; Payasi, Anurag 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 236 KB

A multicenter study on clinical efficacy

✍ Giuliana Gialdroni Grassi 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 661 KB